title: Reversal of graft steatosis after liver transplantation: prospective study.
abstract: OBJECTIVE
  To determine the risk factors for reversal of liver graft steatosis.
  
  
  METHODS
  This prospective study included 70 patients (47 men and 23 women) who received steatotic liver grafts between July 2003 and February 2008. No grafts from prisoners were used in the study. Patients were divided into 3 groups according to degree of liver steatosis, as follows: mild (n = 29, group 1), moderate (n = 23, group 2), and severe (n = 18, group 3).
  
  
  RESULTS
  The median (SD) degree of steatosis in liver grafts at transplantation was 15.7% (7.3%) in group 1, 26.3% (10.5%) in group 2, and 45.1% (8.3%) in group 3. Postoperative histologic analysis demonstrated dramatically decreased steatosis in all graft recipients.
  
  
  CONCLUSIONS
  Graft steatosis can be decreased substantially after liver transplantation. Factors for reversibility of steatosis include donor age, degree of macrovesicular steatosis, and cold ischemia time.
authors.affiliation: Department of Anesthesiology and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, China.
authors.forename: J
authors.initials: J
authors.lastname: Li
authors.forename: B
authors.initials: B
authors.lastname: Liu
authors.forename: L-N
authors.initials: LN
authors.lastname: Yan
authors.forename: Y-X
authors.initials: YX
authors.lastname: Zuo
authors.forename: B
authors.initials: B
authors.lastname: Li
authors.forename: Y
authors.initials: Y
authors.lastname: Zeng
authors.forename: S F
authors.initials: SF
authors.lastname: Zhang
authors.forename: F-G
authors.initials: FG
authors.lastname: Li
mesh_terms: D000328:Adult; D000368:Aged; D001706:Biopsy; D001926:Brain Death; D006528:Carcinoma, Hepatocellular / Q000601:surgery*; D005234:Fatty Liver / Q000145:classification / Q000473:pathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008107:Liver Diseases / Q000145:classification / Q000601:surgery; D008113:Liver Neoplasms / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000145:classification / Q000473:pathology; D011446:Prospective Studies; D014019:Tissue Donors / Q000706:statistics & numerical data